Novartis receives approval from FDA to market Prevacid®24HR as ...
14 May 2009 ... Novartis Institutes for BioMedical Research (NIBR) ... It is the only PPI containing the active ingredient lansoprazole to be approved for ...
http://www.novartis.com/newsroom/media-releases/en/2009/1314...
|
Evaluation of omeprazole, lansoprazole, pantoprazole, and ...
Pantoprazole, which is in the final stages of approval for marketing in the United States, ... Research Support, Non-U.S. Gov't; Review. Mesh Terms: ...
http://www.ncbi.nlm.nih.gov/pubmed/10665250...
|
History 1985-1999 | History | About Takeda | Takeda Pharmaceutical ...
Global Operations · Reports & Publications. Main contents starts here ... Lansoprazole (proton pump inhibitor and anti-peptic ulcer agent) launched in
Europe ... Takeda America Research & Development Center Inc. established ...
Takeda Pharmaceuticals America, Inc. began marketing the insulin sensitizer
Actos® in ...
http://www.takeda.com/about-takeda/history/article_77.html...
|
The rates of common adverse events reported during treatment with ...
For individual patients only the first report of each event was included in the ... Lansoprazole (second on the market) was almost twice as frequently .... The
Drug Safety Research Unit has in the past received donations from Wyeth and ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014999/...
|
Taste Comparisons for Orally Disintegrating Tablets in Children ...
The study was conducted at a contract research organisation site (Hilltop ... a close friend employed by a marketing research company, an advertising agency,
.... Comparative pharmacokinetics and safety of lansoprazole oral capsules and
...
http://www.medscape.com/viewarticle/504566_2...
|
Marketing
Takeda Annual Report 2006. 31. Molecular representation of lansoprazole. Leuprorelin Acetate. Drug delivery system (DDS) research has resulted ...
http://www.takeda.com/pdf/usr/default/ar2006_09_20360_10.pdf...
|
TAP Pharmaceuticals - Wikipedia, the free encyclopedia
... TAP supervises its marketing and sales staff, and ensures that TAP will report to the ... TAP introduces Prevacid NapraPACTM (lansoprazole delayed
release ... TAP enters collaborative research agreement with Ligand
Pharmaceuticals. ...
http://en.wikipedia.org/wiki/TAP_Pharmaceuticals...
|
Search Results | Takeda Pharmaceutical Company Limited
Lansoprazole is marketed in around 90 countries worldwide and is recognized as ... system (DDS) research has resulted in the formulation of leuprorelin acetate
, .... 2.8MB 90PAnnual Report/2006 Marketing PDF 0.4MB 8PAnnual Report/2005 ...
http://www.takeda.com/search/?q=acetate...
|
Article : Redefining Obviousness After KSR Decision Genetic ...
Links · Biotech Companies · Market Reports. About GEN ... Both lansoprazole and rabeprazole are small, lipophilic molecules having a molecular mass of about 360
g/mole. ... Roche Reports Positive Data from Five Phase III Trials of Type 2
Diabetes Therapy ... Tulane Scores $15M to Bolster Research on Lassa Fever ...
http://www.genengnews.com/articles/chitem.aspx?aid=2615...
|
Takeda undertakes global research and development; aiming to ...
Takeda Corporate Social Responsibility Report 2005. 27. Promoting Patient- Focused Research. Prevacid. [Lansoprazole]. Lupron Depot. [Leuprolide]. Blopress
... In July 2005, Takeda received market approval from the U.S. Food and ...
http://www.takeda.com/pdf/usr/default/15_21110_5.pdf...
|
